Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PREGABALIN | 300MG | CAPSULE | Resolved | 2020-10-21 | 2020-11-28 | 126771 |
| APO-PREGABALIN | 150MG | CAPSULE | Actual shortage | 2020-01-22 | 2020-01-22 | 103917 |
| APO-PREGABALIN | 50MG | CAPSULE | Resolved | 2017-06-13 | 2018-01-19 | 12695 |
| APO-PROCAINAMIDE CAP 250MG | 250MG | CAPSULE | Actual shortage | 2017-08-13 | 2017-10-05 | 18976 |
| APO-PROCAINAMIDE CAP 375MG | 375G | CAPSULE | Actual shortage | 2017-08-13 | 2017-10-05 | 18979 |
| APO-PROCAINAMIDE CAP 500MG | 500MG | CAPSULE | Actual shortage | 2017-08-13 | 2017-10-05 | 18982 |
| APO-PROPAFENONE | 300MG | TABLET TABLET | Resolved | 2023-05-06 | 2023-07-07 | 191871 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2021-04-23 | 2021-05-31 | 137968 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2017-05-04 | 2017-07-13 | 8880 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2022-02-11 | 2022-03-25 | 154765 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2020-09-17 | 2020-10-05 | 124356 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2023-04-27 | 2023-07-07 | 190856 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2020-05-08 | 2020-06-08 | 114318 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2017-09-27 | 2018-08-30 | 23632 |
| APO-PROPAFENONE | 300MG | TABLET | Resolved | 2017-03-11 | 2018-08-30 | 460 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2024-03-22 | 2024-04-26 | 223049 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2017-09-04 | 2017-10-27 | 20885 |
| APO-PRUCALOPRIDE | 2MG | TABLET | Resolved | 2020-09-22 | 2020-11-27 | 124795 |
| APO-PRUCALOPRIDE | 2MG | TABLET | Resolved | 2022-08-26 | 2022-12-16 | 168047 |
| APO-PRUCALOPRIDE | 1MG | TABLET | Resolved | 2023-10-06 | 2023-12-01 | 206557 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM - TAB 3MG | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM - TAB 6MG | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |